A UNSW Sydney-led team of scientists has made an advance that could eventually lead to a cure for sickle cell anaemia and other blood disorders.
By introducing a beneficial natural mutation into blood cells using the gene-editing technique CRISPR, a UNSW Sydney-led team of scientists has been able to switch on production of foetal haemoglobin – an advance that could eventually lead to a cure for sickle cell anaemia and other blood disorders.
People with thalassaemia or sickle cell anaemia have damaged adult haemoglobin – the vital molecule that picks up oxygen in the lungs and transports it around the body – and they require life-long treatment with blood transfusions and medication.
However, people with these diseases who also carry the beneficial natural mutation – known as British-198 – have reduced symptoms, because the mutation switches on the foetal haemoglobin gene that is normally turned off after birth.
The extra foetal haemoglobin in their blood, which has a very strong affinity for oxygen, does the work of the defective adult haemoglobin.
“With CRISPR gene-editing we can now precisely cut and alter single genes within our vast genome,” says study senior author and UNSW molecular biologist Professor Merlin Crossley.
“Our laboratory has shown that introducing the beneficial mutation British-198 into blood cells using this technology substantially boosts their production of foetal haemoglobin.
“Because this mutation already exists in nature and is benign, this ‘organic gene therapy’ approach should be effective and safe to use to treat, and possibly cure serious blood disorders. However, more research is still needed before it can be tested in people,” he says.
The study by scientists from UNSW, the Japanese Red Cross Society and the RIKEN BioResource Centre in Japan, is published in the journal Blood.
The beneficial British-198 mutation, which was first identified in a large British family in 1974, involves a change in just a single letter of the genetic code.
Carriers of this mutation have foetal haemoglobins levels as high as 20% of total haemoglobin, while most people’s foetal haemoglobin levels fall to about 1% of total haemoglobin after birth.
The researchers also discovered how this British-198 mutation works. They found it creates a new binding site for a protein called KLF1 that turns blood genes on.
Mutations affecting adult haemoglobin production are among the most common of all genetic variations, with about 5% of the world’s population carrying a defective gene.
“To turn the new gene editing approach into a therapy for blood disorders, the British-198 mutation would have to be introduced into blood-forming stem cells from the patient,” says Professor Crossley.
“A large number of stem cells would have to be edited in order to repopulate the patients’ blood with genetically enhanced cells.”
The Latest on: Genome therapy
- Targeting the vasopressin type-2 receptor for renal cell carcinoma therapyon October 15, 2019 at 12:20 pm
The current studies investigated V2R expression and activity in human RCC tumors, and its role in RCC tumor growth. Examination of the cancer genome atlas (TCGA) database, and analysis of human RCC ...
- CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies' Respective Cell Therapy Programs in Oncologyon October 15, 2019 at 4:01 am
These specific targets were uncovered in screens to identify genetic edits that could enhance the functionality and quality of ... and has identified a group of targets that could help unlock the full ...
- High Intensity Focused Ultrasound Therapy Market to 2027 - Global Analysis and Forecasts by Modality, Method, Application, End User and Geographyon October 14, 2019 at 5:25 pm
Genetic testing helps evaluate the chance of developing cancer in a lifetime.The ... Therapeutic ultrasound segment held a largest market share of the High-Intensity Focused Ultrasound therapy ...
- Experts explain who should consider genetic testing for breast canceron October 14, 2019 at 1:07 pm
Moroose: Every cancer is genetic, only about 5 to 10 percent is because of an inherited gene, the rest is because something was acquired during your lifetime, a gene went wrong, and caused cancer. So ...
- Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristicson October 14, 2019 at 11:28 am
Together, these findings helped to define the most optimized vector to date for human TM gene therapy (sc2.Y3). Our study also revealed that there is an individual component to the transduction ...
- A rare genetic disease led to depression at age 6 for this CHKD patient. He wants to “inspire kids to never give up.”on October 14, 2019 at 9:00 am
Every Monday, Julian comes here to the Children’s Hospital of The King’s Daughters’ Oakbrooke health center, in Chesapeake, for a physical therapy appointment to help him strengthen his muscles and ...
- New Technology Can Identify Bacteria's Genetic Make-Up, Fight Drug Resistanceon October 14, 2019 at 8:53 am
A new diagnostic tool that identifies bacteria quickly, at a genetic level, might help patients and fight antibiotic resistance ... For the vast majority of them, about 8 million a year, you can ...
- Custom-made oligonucleotide therapy for girl with fatal Batten diseaseon October 14, 2019 at 7:32 am
The cause of these irreversible and highly impactful symptoms on the affected person’s quality of life is due to a variety of genetic mutations. These mutations prevent the cells usual function of ...
- Cell and Gene Therapy Market Register a Hugh Growth In Healthcare Industry by 2026on October 14, 2019 at 1:16 am
Increasing prevalence of cardiovascular diseases and cancer is expected to boost growth of cell and gene therapy market Gene therapy is used to modify the course of various genetic and acquired ...
- Researchers Try A Genetic Diabetes Test To Prevent Emergency Hospitalizationson October 14, 2019 at 12:47 am
"It's a much better course of initiating therapy," he says. "They stay out of the ICU. They even stay out of the hospital, in most cases." If the University of Virginia team can demonstrate the value ...
via Google News and Bing News